U.S. Governemnt Files Brief in Myriad
11:08 EDT 16 Jun 2012 | Holman's Biotech IP Blog
The U.S. has filed a brief in Myriad, available here, which argues that under Mayo “isolated but otherwise unmodified DNA molecules are not patent-eligible because they are products of nature, not human-made inventions.” The government also argue..
Original Article: U.S. Governemnt Files Brief in Myriad
More From BioPortfolio on "U.S. Governemnt Files Brief in Myriad"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
